LDV

DEVICE2 trials

Sponsors

Gilead Sciences, Medical University of Vienna

Conditions

Chronic Hepatitis C InfectionHealthy

Phase 2

Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3

CompletedNCT01260350

Gilead SciencesChronic Hepatitis C Infection

Start: 2010-12-31End: 2013-12-31Updated: 2014-11-17

Unknown Phase

Measurement of Total Retinal Blood Flow During Flicker Stimulation in Healthy Subjects

CompletedNCT02531399

Medical University of ViennaHealthy

Start: 2015-10-31End: 2017-09-30Updated: 2017-09-06

Related Papers

Measurement of Retinal Vascular Caliber From Optical Coherence Tomography Phase Images

Investigative Ophthalmology & Visual Science2016-07-1319 citations

Efficacy of nucleotide polymerase inhibitor sofosbuvir plus the NS5A inhibitor ledipasvir or the NS5B non-nucleoside inhibitor GS-9669 against HCV genotype 1 infection.

2013-11-18143 citations

Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C.

2013-01-01510 citations